Skip to main content
Erschienen in: AIDS and Behavior 6/2010

01.12.2010 | Original Paper

Using Mobile Phones to Improve Clinic Attendance Amongst an Antiretroviral Treatment Cohort in Rural Uganda: A Cross-sectional and Prospective Study

verfasst von: Setor Kunutsor, John Walley, Elly Katabira, Simon Muchuro, Hudson Balidawa, Elizabeth Namagala, Eric Ikoona

Erschienen in: AIDS and Behavior | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

We aimed to assess the patterns and dynamics of mobile phone usage amongst an antiretroviral treatment (ART) cohort in rural Uganda and ascertain its feasibility for improving clinic attendance. A cross-sectional study of clients on ART exploring their access to mobile phones and patterns of use was employed. Clinic attendances for antiretroviral drug refills were then monitored prospectively over 28 weeks in 176 patients identified in the cross-sectional survey who had access to mobile phones and had given consent to be contacted. Patients were contacted via voice calls or text messages to remind them about their missed clinic appointments. Of the 276 patients surveyed, 177 (64%) had access to mobile phones with all but one were willing to be contacted for missed visits reminders. Of the 560 total scheduled clinic appointments, 62 (11%) were missed visits. In 79% of episodes in which visits were missed, patients presented for treatment within a mean duration of 2.2 days (SD = 1.2 days) after mobile phone recall. Access to mobile phones was high in this setting. Privacy and confidentiality issues were not considered deterrents. Mobile phones have a potential for use in resource-constrained settings to substantially improve the clinical management of HIV/AIDS.
Literatur
2.
Zurück zum Zitat Detels R, Munoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA. 1998;280:1497–503.CrossRefPubMed Detels R, Munoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA. 1998;280:1497–503.CrossRefPubMed
3.
Zurück zum Zitat Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMed Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMed
4.
Zurück zum Zitat Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001;33:1417–23.CrossRefPubMed Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001;33:1417–23.CrossRefPubMed
5.
Zurück zum Zitat Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181–3.CrossRefPubMed Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181–3.CrossRefPubMed
6.
Zurück zum Zitat Turner BJ. Adherence to antiretroviral therapy by HIV-infected patients. J Infect Dis. 2002;185(2):143–51.CrossRef Turner BJ. Adherence to antiretroviral therapy by HIV-infected patients. J Infect Dis. 2002;185(2):143–51.CrossRef
7.
Zurück zum Zitat Gardner EM, Burman WJ, Steiner JF, Anderson PL, Bangsberg DR. Antiretroviral medication adherence and class-specific antiretroviral resistance. AIDS. 2009;23(9):1035–46.CrossRefPubMed Gardner EM, Burman WJ, Steiner JF, Anderson PL, Bangsberg DR. Antiretroviral medication adherence and class-specific antiretroviral resistance. AIDS. 2009;23(9):1035–46.CrossRefPubMed
8.
Zurück zum Zitat Parienti J-J, Das-Douglas M, Massari V, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS ONE. 2008;3(7):e2783.CrossRefPubMed Parienti J-J, Das-Douglas M, Massari V, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS ONE. 2008;3(7):e2783.CrossRefPubMed
9.
Zurück zum Zitat Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1990;131:81–7. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1990;131:81–7.
10.
Zurück zum Zitat Rastegar DA, Fingerhood MI, Jasinki DR. Highly active antiretroviral therapy outcomes in a primary care clinic. AIDS Care. 2003;15:231–7.CrossRefPubMed Rastegar DA, Fingerhood MI, Jasinki DR. Highly active antiretroviral therapy outcomes in a primary care clinic. AIDS Care. 2003;15:231–7.CrossRefPubMed
11.
Zurück zum Zitat Park WB, Choe PG, Kim SH, et al. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patient. J Intern Med. 2007;261:268–75.CrossRefPubMed Park WB, Choe PG, Kim SH, et al. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patient. J Intern Med. 2007;261:268–75.CrossRefPubMed
12.
Zurück zum Zitat Levine AM, Richardson JL, Marks G, et al. Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol. 1987;5:1469–76.PubMed Levine AM, Richardson JL, Marks G, et al. Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol. 1987;5:1469–76.PubMed
13.
Zurück zum Zitat Wood PR, Casey R, Kolski GB, McCormick MC. Compliance with oral theophylline therapy in asthmatic children. Ann Allergy. 1985;54:400–4.PubMed Wood PR, Casey R, Kolski GB, McCormick MC. Compliance with oral theophylline therapy in asthmatic children. Ann Allergy. 1985;54:400–4.PubMed
14.
Zurück zum Zitat Giordano TP, Gifford AL, Clinton White A, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44:1493–9.CrossRefPubMed Giordano TP, Gifford AL, Clinton White A, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44:1493–9.CrossRefPubMed
15.
Zurück zum Zitat Laurent C, Diakhate N, Fatou Ngom Gueye N, et al. The Senegalese government’s highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS. 2002;16(10):1363–70.CrossRefPubMed Laurent C, Diakhate N, Fatou Ngom Gueye N, et al. The Senegalese government’s highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS. 2002;16(10):1363–70.CrossRefPubMed
16.
Zurück zum Zitat Orrell C, Bangsberg D, Badri M, Wood R. Adherence is not a barrier to delivery of HIV antiretroviral therapy in resource-poor countries. AIDS. 2003;17:1369–75.CrossRefPubMed Orrell C, Bangsberg D, Badri M, Wood R. Adherence is not a barrier to delivery of HIV antiretroviral therapy in resource-poor countries. AIDS. 2003;17:1369–75.CrossRefPubMed
18.
Zurück zum Zitat World Health Organization. WHA58.28 e-Health. Geneva: WHO; 2005. World Health Organization. WHA58.28 e-Health. Geneva: WHO; 2005.
19.
Zurück zum Zitat World Health Organization. Strategy 2004–2007. E-health for health care delivery. Geneva: WHO; 2004. World Health Organization. Strategy 2004–2007. E-health for health care delivery. Geneva: WHO; 2004.
22.
Zurück zum Zitat Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968–77.PubMed Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968–77.PubMed
25.
Zurück zum Zitat Ronald A, Plummer F, Ngugi E, et al. The Nairobi STD program. An international partnership. Infect Dis Clin North Am. 1991;5:337–52.PubMed Ronald A, Plummer F, Ngugi E, et al. The Nairobi STD program. An international partnership. Infect Dis Clin North Am. 1991;5:337–52.PubMed
26.
Zurück zum Zitat Kaplan WA. Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Glob Health. 2006;2:9.CrossRef Kaplan WA. Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Glob Health. 2006;2:9.CrossRef
28.
Zurück zum Zitat Downer SR, Meara JG, Da Costa AC. Use of SMS text messaging to improve outpatient attendance. Med J Aust. 2005;183:366–8.PubMed Downer SR, Meara JG, Da Costa AC. Use of SMS text messaging to improve outpatient attendance. Med J Aust. 2005;183:366–8.PubMed
29.
Zurück zum Zitat Collier AC, Ribaudo H, Mukherjee AL, Feinberg J, Fischl MA, Chesney M. A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy. J Infect Dis. 2005;192:1398–1398.CrossRefPubMed Collier AC, Ribaudo H, Mukherjee AL, Feinberg J, Fischl MA, Chesney M. A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy. J Infect Dis. 2005;192:1398–1398.CrossRefPubMed
31.
Zurück zum Zitat Sawyer SM, Zalan A, Bond LM. Telephone reminders improve adolescent clinic attendance: a randomized controlled trial. J Paediatr Child Health. 2002;38(1):79–83.CrossRefPubMed Sawyer SM, Zalan A, Bond LM. Telephone reminders improve adolescent clinic attendance: a randomized controlled trial. J Paediatr Child Health. 2002;38(1):79–83.CrossRefPubMed
Metadaten
Titel
Using Mobile Phones to Improve Clinic Attendance Amongst an Antiretroviral Treatment Cohort in Rural Uganda: A Cross-sectional and Prospective Study
verfasst von
Setor Kunutsor
John Walley
Elly Katabira
Simon Muchuro
Hudson Balidawa
Elizabeth Namagala
Eric Ikoona
Publikationsdatum
01.12.2010
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 6/2010
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9780-2

Weitere Artikel der Ausgabe 6/2010

AIDS and Behavior 6/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.